These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 24747343)

  • 1. Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: insight from animal models.
    Roland AV; Moenter SM
    Front Neuroendocrinol; 2014 Oct; 35(4):494-511. PubMed ID: 24747343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.
    Blank SK; McCartney CR; Marshall JC
    Hum Reprod Update; 2006; 12(4):351-61. PubMed ID: 16670102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome.
    McGee WK; Bishop CV; Bahar A; Pohl CR; Chang RJ; Marshall JC; Pau FK; Stouffer RL; Cameron JL
    Hum Reprod; 2012 Feb; 27(2):531-40. PubMed ID: 22114112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prepubertal Development of GABAergic Transmission to Gonadotropin-Releasing Hormone (GnRH) Neurons and Postsynaptic Response Are Altered by Prenatal Androgenization.
    Berg T; Silveira MA; Moenter SM
    J Neurosci; 2018 Feb; 38(9):2283-2293. PubMed ID: 29374136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological pulses in PCOS.
    Coyle C; Campbell RE
    Mol Cell Endocrinol; 2019 Dec; 498():110561. PubMed ID: 31461666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of arcuate nucleus GABA neurons promotes luteinizing hormone secretion and reproductive dysfunction: Implications for polycystic ovary syndrome.
    Silva MSB; Desroziers E; Hessler S; Prescott M; Coyle C; Herbison AE; Campbell RE
    EBioMedicine; 2019 Jun; 44():582-596. PubMed ID: 31178425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
    Blank SK; McCartney CR; Helm KD; Marshall JC
    Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental programming of the neuroendocrine axis by steroid hormones: Insights from the sheep model of PCOS.
    Gurule S; Sustaita-Monroe J; Padmanabhan V; Cardoso R
    Front Endocrinol (Lausanne); 2023; 14():1096187. PubMed ID: 36755919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood.
    Tata B; Mimouni NEH; Barbotin AL; Malone SA; Loyens A; Pigny P; Dewailly D; Catteau-Jonard S; Sundström-Poromaa I; Piltonen TT; Dal Bello F; Medana C; Prevot V; Clasadonte J; Giacobini P
    Nat Med; 2018 Jun; 24(6):834-846. PubMed ID: 29760445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of gonadotropin-releasing hormone neurons in polycystic ovary syndrome.
    McCartney CR; Campbell RE; Marshall JC; Moenter SM
    J Neuroendocrinol; 2022 May; 34(5):e13093. PubMed ID: 35083794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine control in polycystic ovary-like syndrome.
    Schoemaker J
    Gynecol Endocrinol; 1991 Dec; 5(4):277-88. PubMed ID: 1796749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic androgen excess in female mice does not impact luteinizing hormone pulse frequency or putative GABAergic inputs to GnRH neurons.
    Coyle CS; Prescott M; Handelsman DJ; Walters KA; Campbell RE
    J Neuroendocrinol; 2022 Apr; 34(4):e13110. PubMed ID: 35267218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome.
    Barontini M; García-Rudaz MC; Veldhuis JD
    Arch Med Res; 2001; 32(6):544-52. PubMed ID: 11750729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatments targeting neuroendocrine dysfunction in polycystic ovary syndrome (PCOS).
    Garg A; Patel B; Abbara A; Dhillo WS
    Clin Endocrinol (Oxf); 2022 Aug; 97(2):156-164. PubMed ID: 35262967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine aspects of polycystic ovary syndrome.
    Marshall JC; Eagleson CA
    Endocrinol Metab Clin North Am; 1999 Jun; 28(2):295-324. PubMed ID: 10352920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine dysfunction in polycystic ovary syndrome.
    Burt Solorzano CM; Beller JP; Abshire MY; Collins JS; McCartney CR; Marshall JC
    Steroids; 2012 Mar; 77(4):332-7. PubMed ID: 22172593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental Programming: Insulin Sensitizer Prevents the GnRH-Stimulated LH Hypersecretion in a Sheep Model of PCOS.
    Cardoso RC; Burns A; Moeller J; Skinner DC; Padmanabhan V
    Endocrinology; 2016 Dec; 157(12):4641-4653. PubMed ID: 27792406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
    McCartney CR; Eagleson CA; Marshall JC
    Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic-pituitary, ovarian and adrenal contributions to polycystic ovary syndrome.
    Baskind NE; Balen AH
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():80-97. PubMed ID: 27137106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrinology of the polycystic ovary syndrome.
    Soule SG
    Baillieres Clin Endocrinol Metab; 1996 Apr; 10(2):205-19. PubMed ID: 8773745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.